Trademarkia Logo

Canada

C$
A & DESIGN
FORMALIZED

on 6 Oct 2023

Last Applicant/ Owned by

MERCURY PHARMA GROUP LIMITED

Dashwood House69 Old Broad StreetLondon, EC2M 1QS

GB

Serial Number

2285542 filed on 6th Oct 2023

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

A & DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial Read More

Vienna Information


27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

29 . 1 . 3

GreenVert

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells


Classification kind code

12

Mark Details


Serial Number

2285542

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 19th Oct 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 6th Oct 2023
Filed
Submitted for opposition 1
on 6th Oct 2023
Created
Submitted for opposition 31
on 6th Oct 2023
Formalized